by qfrsolutions | May 13, 2016 | News
Source: Mylan may have failed in its effort to buy OTC specialist Perrigo ($PRGO), but it is trying to quickly move on. Three months after announcing its $7.2 billion deal for Sweden’s Meda, the company says it will spend about $1 billion to get pick up topical...
by qfrsolutions | May 6, 2016 | News
Source: Bloomberg Bill Baer was the ultimate Washington antitrust insider when he came to the Justice Department in 2013: At law firm Arnold & Porter LLP, he’d counseled the biggest U.S. companies, including deal machine General Electric Co., on getting mergers...
by qfrsolutions | Apr 29, 2016 | News
Source: by Emily Wasserman | Apr 25, 2016 8:47am Pfizer ($PFE) has been trying to get the FDA to take the black box warning off its smoking cessation drug, Chantix, after regulators warned that the med could be linked to serious psychiatric side effects. Now, the...
by qfrsolutions | Apr 28, 2016 | News
Source: April 27, 2016 10:40 AM Eastern Daylight Time FRANKFURT AM MAIN & BOSTON–(BUSINESS WIRE)–Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat...
by qfrsolutions | Apr 22, 2016 | News
Source: FierceBiotech by John Carroll | Apr 21, 2016 5:02pm Allergan is racking up another new deal in the wake of its broken merger with Pfizer. Thursday evening the company announced a deal to buy Boston-based Topokine Therapeutics for $85 million up front. The...
